Sitavig Articles

BioAlliance Pharma's Sitavig OKed by US FDA for Herpes labialis

16 April 2013

BioAlliance gains registration of Sitavig in eight European countries

20 December 2012

Teva gets rights to BioAlliance's Sitavig in Israel

14 June 2012

BioAlliance's Sitavig NDA "receivable" by US FDA

30 May 2012

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end